Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety and Efficacy of CAIV-T Co-administered with MMR in Healthy Children
NCT00192166Phase 2Completed
- Sponsor
- MedImmune
- Start
- Oct 2002
- Primary completion
- Mar 2003
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 2 trial of live attenuated influenza vaccine in influenza, sponsored by MedImmune. Started Oct 2002; status: completed.
02
Drugs
live attenuated influenza vaccine
03
Conditions
influenza
Beyond the preview
Go deeper on NCT00192166.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00192166.